Your browser doesn't support javascript.
loading
GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects.
Desai, Avanti; Sowerwine, Kathryn; Liu, Yihui; Lawrence, Monica G; Chovanec, Jack; Hsu, Amy P; O'Connell, Michael P; Kim, Jiwon; Boris, Lisa; Jones, Nina; Wisch, Laura; Eisch, Robin R; Carter, Melody C; Komarow, Hirsh D; Zerbe, Christa; Milner, Joshua D; Maric, Irina; Sun, Xiaoping; Lee, Chyi-Chia R; Tunc, Ilker; Pirooznia, Mehdi; Stone, Kelly D; Holland, Steven M; Metcalfe, Dean D; Lyons, Jonathan J.
Afiliação
  • Desai A; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Sowerwine K; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Liu Y; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Lawrence MG; Division of Asthma, Allergy and Immunology, Department of Medicine, University of Virginia, Charlottesville, Va.
  • Chovanec J; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Hsu AP; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • O'Connell MP; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Kim J; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Boris L; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Jones N; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Md.
  • Wisch L; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Eisch RR; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Carter MC; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Komarow HD; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Zerbe C; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Milner JD; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Maric I; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Md.
  • Sun X; Department of Laboratory Medicine, National Institutes of Health, Bethesda, Md.
  • Lee CR; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md.
  • Tunc I; Bioinformatics and Computational Biology Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.
  • Pirooznia M; Bioinformatics and Computational Biology Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.
  • Stone KD; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Holland SM; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Metcalfe DD; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Lyons JJ; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. Electronic address: jonathan.lyons@nih.gov.
J Allergy Clin Immunol ; 144(2): 613-617.e14, 2019 08.
Article em En | MEDLINE | ID: mdl-31102699

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Deficiência de GATA2 / Hipersensibilidade Imediata Limite: Female / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Deficiência de GATA2 / Hipersensibilidade Imediata Limite: Female / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2019 Tipo de documento: Article